Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells

Tiziana Notarangelo(Centro di Riferimento Oncologico della Basilicata), Matteo Landriscina(University of Foggia)
Cancer Cell International
October 4, 2017
Cited by 36


Related Papers